Advanced Biologics and Vaccine Development

Oladimeji Tolib Fashola

CEO/Founder
Advanced Biologics and Vaccine Development
  • Advancing mRNA workforce development and translational education initiatives across West Africa through hands-on technical training programs focused on mRNA manufacturing, formulation, and vaccine development workflows.
  • Collaborating with academic and research institutions in Nigeria to support the development of mRNA-focused training curricula and long-term capacity-building pathways for graduate-level biotechnology and vaccine development programs.
  • Supporting ecosystem development for regional biomanufacturing and RNA-based therapeutics by facilitating cross-sector engagement between academia, research institutes, and emerging biotechnology stakeholders.
  • Working toward the establishment of scalable training and innovation frameworks that strengthen local scientific talent, technology transfer readiness, and sustainable mRNA infrastructure development across Africa.